Thus, we further showed that IL-22 expression (protein and mRNA) in CD4+ T cells from tumor site was elevated than those from nontumor site, indicating that elevated IL-22 expression in BALF might be due to the increased production by CD4+ T cells, not lung adenocarcinoma cells. This evidence concerns the gene IL22 and lung adenocarcinoma.